ASTX727
Drug timelines are a Plus or Pro feature.
31 regulatory and trial events tracked for ASTX727, covering 2024-07-01 to 2026-04-24. Get the full timeline:
Most recent: Clinical Trial Update: Testing the Anti-cancer Drug, Cirtuvivint, and Its Combination With ASTX727 to Improve Outcomes in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndromes [Phase 1]